Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

Blog

Claudin18.2 CAR-T (CT041) in Patients With Gastric or Pancreatic Cancer
Conditions:   Gastric Cancer;   Pancreatic Cancer
Intervention:   Biological: CT041
Sponsor:   Carsgen Therapeutics, Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Cerebrospinal Fluid Biomarkers in Bariatric Surgery
Condition:   Obesity
Interventions:   Procedure: Roux-en-Y Gastric Bypass (RYGB);   Procedure: Sleeve Gastrectomy (SG);   Behavioral: Very Low Calorie Diet (VLCD)
Sponsor:   Columbia University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
The Effects of Terminalia Chebula Fruit Extract on the Gut Microbiome and Skin Biophysical Properties
Condition:   Human Microbiome
Interventions:   Dietary Supplement: Terminalia Chebula fruit extract;   Dietary Supplement: Placebo;   Other: Topical Terminalia Chebula;   Other: Topical Placebo
Sponsors:   Integrative Skin Science and Research;   Sytheon Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris
Condition:   Acne Vulgaris
Interventions:   Dietary Supplement: Probiotic;   Dietary Supplement: Placebo
Sponsors:   Integrative Skin Science and Research;   Microbiome labs
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
ToothWave Calculus Reduction and Accumulation Prevention Study
Conditions:   Gingivitis;   Plaque;   Calculus, Dental
Interventions:   Device: RF-utilizing powered toothbrush;   Device: Control placebo with no RF
Sponsor:   Home Skinovations Ltd.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
TVEC and Preop Radiation for Sarcoma (8 ml Dose)
Condition:   Soft Tissue Sarcoma
Interventions:   Drug: Talimogene Laherparepvec;   Radiation: Radiotherapy
Sponsors:   Varun Monga, MD;   Amgen
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Addressing Barriers to Palliative Care Use in Bladder Cancer
Conditions:   Muscle-Invasive Bladder Carcinoma;   Bladder Cancer Stage II;   Bladder Cancer Stage III;   Bladder Cancer Stage IV
Intervention:   Other: Surveys
Sponsor:   H. Lee Moffitt Cancer Center and Research Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction
Conditions:   Breast Cancer;   Mastectomy; Lymphedema;   Same Day Surgery;   Nipple-sparing Mastectomy;   Skin-sparing Mastectomy
Intervention:   Procedure: Same-day NSM or SSM
Sponsor:   Georgetown University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
Conditions:   Melanoma;   Non-small Cell Lung Cancer;   Squamous Cell Carcinoma of Head and Neck;   Urothelial Carcinoma;   Renal Cell Carcinoma;   Small-cell Lung Cancer;   Cutaneous Squamous Cell Carcinoma;   Anal Squamous Cell Carcinoma
Interventions:   Biological: GEN-011;   Drug: IL-2;   Drug: Fludarabine;   Drug: Cyclophosphamide
Sponsor:   Genocea Biosciences, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in
A Trial Testing Chemo Mouthpiece Device and Best Supportive Care Against Best Supportive Care Only for Symptoms of Oral Mucositis in Patients Receiving Chemotherapy
Condition:   Oral Mucositis
Interventions:   Device: Chemo Mouthpiece;   Other: Best Supportive Care only
Sponsor:   Chemo Mouthpiece
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 23, 2020 / by / in